# ProvaLabs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/provalabs

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Latest round: Seed (Feb 5, 2024)
- Investors on record: 1

## About

Founded in 2021 and based in Seoul, South Korea, ProvaLabs, Inc. operates as a developer of sensor solutions for biological model evaluation. In April 2026, ProvaLabs, Inc. raised KRW 2.06 billion in pre-series A funding from new investors Capstone Partners and Life Asset Management. Returning investor Seoul Technology Holdings also participated in this round. As of 2024, the company is led by its CEO, Ha Seung-jae.

The company offers solutions for the drug development process by enhancing the efficiency and cost-effectiveness of active pharmaceutical ingredient (API) verification. 

The company provides biofunctional chips, which integrate three-dimensional (3D) cell culture technology with microfluidic technology.

The company will use the April 2026 funding to accelerate the commercialization of its organoid analysis sensors and expand into the global market.

## Funding rounds

- Seed, Feb 5, 2024 — Seoul Technology Holdings

## Investors

- Seoul Technology Holdings (https://capitalatlas.ai/funds/seoul-technology-holdings) — Seed